𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Small-cell lung cancer: An overview of issues in therapy

✍ Scribed by Robert E. Wittes

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
917 KB
Volume
9
Category
Article
ISSN
8756-0437

No coin nor oath required. For personal study only.

✦ Synopsis

As one of the few chemo-and radiosensitive neoplasms among the common epithelial solid tumors of adults, small-cell lung cancer has long tantalized clinical investigators. Although for the last 15-20 years therapy has yielded high remission rates, including substantial complete remission rates, results have not improved very much over nearly two decades of intensive therapeutic research, and long-term diseasefree survival remains an elusive goal for the large majority of patients. At this point the number of promising untested hypotheses in therapy is quite small, and major advances will probably have to await either the serendipitous discovery of much more active drugs than we now possess, or else the purposeful development of new approaches based on insights into the nature of the transformed state and the biology of SCLC itself. @ 1993 Wiley-Liss, Inc.

πŸ“œ SIMILAR VOLUMES

Adjuvant therapy of non-small cell lung
Adjuvant therapy of non-small cell lung cancer
✍ E. Carmack Holmes πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 251 KB πŸ‘ 2 views

One hundred and forty thousand patients in the United States will develop lung cancer annually. About one half of these will have disease confined to the thorax with no clinical evidence of dissemination (Figure 1). A relatively high proportion of these patients will actually have disease that can b

Incorporation of photodynamic therapy as
Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer
✍ Patrick Ross Jr.; John Grecula; Tanios Bekaii-Saab; Miguel Villalona-Calero; Gre πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 273 KB

## Background and objectives: Incorporation of photodynamic therapy (pdt) into the induction therapy regimen utilized for treatment of locally advanced primary non-small cell bronchogenic carcinoma (nsclc) is explored. ## Study design/materials and methods: We present a retrospective review of 41

Recent advances in etoposide therapy for
Recent advances in etoposide therapy for non-small cell lung cancer
✍ Philip Bonomi πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 504 KB

Non-small cell lung cancer (NSCLC) continues to be a major health problem in the US. In 1990, approximately 120,000 new cases will be diagnosed, and the majority of these patients will have either unresectable disease or resected disease that has a relatively low chance of being cured. A variety of